In vitro anti-tumour activity of α-galactosylceramide-stimulated human invariant Vα24+NKT cells against melanoma (original) (raw)

References

• Azzoni, L, Zatsepina, O, Abebe, B, Bennett, IM, Kanakaraj, P & Perussia, B (1998). Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells. J Immunol, 161, 3493–3500.
  CAS PubMed Google Scholar
• Bezouska, K, Yuen, CT, O’Brien, J, Childs, RA, Chai, W, Lawson, AM, Drbal, K, Fiserova, A, Pospisil, M & Feizi, T (1994). Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity (published erratum appears in Nature 1996 Apr 11 380(6574) 559). Nature, 372, 150–157.
  Article CAS Google Scholar
• Burdin, N, Brossay, L & Kronenberg, M (1999). Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol, 29, 2014–2025.
  Article CAS Google Scholar
• Calabi, F & Bradbury, A (1991). The CD1 system. Tissue Antigens, 37, 1–9.
  Article CAS Google Scholar
• Couedel, C, Peyrat, MA, Brossay, L, Koezuka, Y, Porcelli, SA, Davodeau, F & Bonneville, M (1998). Diverse CD1d-restricted reactivity patterns of human T cells bearing ‘invariant’ AV24BV11 TCR. Eur J Immunol, 28, 4391–4397.
  Article CAS Google Scholar
• Cui, J, Shin, T, Kawano, T, Sato, H, Kondo, E, Toura, I, Kaneko, Y, Koseki, H, Kanno, M & Taniguchi, M (1997). Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumours. Science, 278, 1623–1626.
  Article CAS Google Scholar
• Dellabona, P, Padovan, E, Casorati, G, Brockhaus, M & Lanzavecchia, A (1994). An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells. J Exp Med, 180, 1171–1176.
  Article CAS Google Scholar
• Fujimoto, T, O’Donnell, MA, Szilvasi, A, Yang, H & Duda, RB (1996). Bacillus Calmette-Guerin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro. Cancer Immunol Immunother, 42, 280–284.
  Article CAS Google Scholar
• Gillis, S & Williams, DE (1998). Cytokine therapy: lessons learned and future challenges (editorial). Curr Opin Immunol, 10, 501–503.
  Article CAS Google Scholar
• Kawano, T, Cui, J, Koezuka, Y, Toura, I, Kaneko, Y, Sato, H, Kondo, E, Harada, M, Koseki, H, Nakayama, T, Tanaka, Y & Taniguchi, M (1998). Natural killer-like nonspecific tumour cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci USA, 95, 5690–5693.
  Article CAS Google Scholar
• Kawano, T, Cui, J, Koezuka, Y, Toura, I, Kaneko, Y, Motoki, K, Ueno, H, Nakagawa, R, Sato, H, Kondo, E, Koseki, H & Taniguchi, M (1997). CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science, 278, 1626–1629.
  Article CAS Google Scholar
• Kawano, T, Nakayama, T, Kamada, N, Kaneko, Y, Harada, M, Ogura, N, Akutsu, Y, Motohashi, S, Iizasa, T, Endo, H, Fujisawa, T, Shinkai, H & Taniguchi, M (1999). Antitumour cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res, 59, 5102–5105.
  CAS PubMed Google Scholar
• Kitamura, H, Iwakabe, K, Yahata, T, Nishimura, S, Ohta, A, Ohmi, Y, Sato, M, Takeda, K, Okumura, K, Van Kaer, L, Kawano, T, Taniguchi, M & Nishimura, T (1999). The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med, 189, 1121–1128.
  Article CAS Google Scholar
• Kobayashi, E, Motoki, K, Uchida, T, Fukushima, H & Koezuka, Y (1995). KRN7000, a novel immunomodulator, and its antitumour activities. Oncol Res, 7, 529–534.
  CAS PubMed Google Scholar
• Nicol, AJ, Nieda, M, Koezuka, Y, Porcelli, S, Suzuki, K, Tadokoro, K, Durrant, S & Juji, T (2000). Human invariant Vα24+ NKT cells activated by α-GalactosylCeramide (KRN7000) have cytotoxic antitumour activity through mechanisms distinct from T cells and NK cells. Immunology, 99, 229–234.
  Article CAS Google Scholar
• Nieda, M, Nicol, A, Koezuka, Y, Kikuchi, A, Takahashi, T, Nakamura, H, Furukawa, H, Yabe, T, Ishikawa, Y, Tadokoro, K & Juji, T (1999). Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum Immunol, 60, 10–19.
  Article CAS Google Scholar
• Takahashi, T, Nieda, M, Koezuka, Y, Nicol, A, Porcelli, SA, Ishikawa, Y, Tadokoro, K, Hirai, H & Juji, T (2000). Analysis of human Va24+CD4+NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. J of Immunology, 164, 4458–4464.
  Article CAS Google Scholar
• Yue, FY, Geertsen, R, Hemm, S, Burg, G, Pavlovic, J, Laine, E & Dummer, R (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumour activity?. Eur J Immunol, 29, 1762–1773.
  Article CAS Google Scholar

Download references